US 8101647
Spiro-oxindole compounds and their use as therapeutic agents
granted A61PA61P11/00A61P25/00
Quick answer
US patent 8101647 (Spiro-oxindole compounds and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61P, A61P11/00, A61P25/00, A61P29/00, A61P35/00